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Bacteremia Caused by Corynebacterium amycolatum with a Novel 
Mutation in gyrA Gene that Confers High-Level Quinolone Resistance
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Although Corynebacterium amycolatum can cause opportunistic infections, it is commonly considered as contaminant. In this re-
port, we present a case of bacteremia caused by C. amycolatum with a novel mutation in the gyrA gene that confers high-level qui-
nolone resistance to the organism.
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INTRODUCTION
Corynebacterium species except Corynebacterium diph-
theriae are part of the normal flora of the skin and mucous 
membrane and occur as common contaminants in diag-
nostic specimens. Therefore, physicians often tend to con-
sider these organisms as contaminants. However, these mi-
croorganisms have increasingly been recognized as patho-
gens in immunocompromised patients [1]. Corynebacte-
rium amycolatum, in particular, is a common clinical isolate 
that often shows multidrug resistance to commonly used 
antibiotics such as β-lactams, macrolides, and fluoroquino-
lones [2, 3]. In this report, we present a case of bacteremia 
caused by C. amycolatum possessing a novel mutation in 
the gyrA gene, which confers high-level quinolone resis-
tance to the organism.
CASE REPORT
An 88-yr-old man with diabetes mellitus presented to our 
emergency department with chest pain. There was no defi-
nite evidence of acute coronary syndrome, but laboratory 
examination findings indicated impending end-stage renal 
disease. Hemodialysis was performed through a subclavian 
double-lumen catheter on alternate days. After 3 sessions of 
hemodialysis, on the 11th hospital day, the patient developed 
fever (temperature, 38.0℃), and the blood profile showed a 
total white blood cell count of 8,800/µL with 74% neutro-
phils and an elevated C-reactive protein level of 134.2 mg/L. 
Hence, samples for blood culture were drawn in triplicate, 
and empiric antibiotic therapy was initiated with 200 mg of 
ciprofloxacin administered intravenously every 12 hr. On 
the 14th hospital day, after 72 hr of incubation, “diphthe-
roid-like organisms” were detected in all 3 aerobic blood-
culture bottles. Although the patient had fever and elevated 
C-reactive protein level, which do indicate bacteremia, the 
positive blood culture was considered to show merely con-
taminants, and therefore, additional blood cultures were 
performed to identify the causative agent. The repeated blood 
cultures yielded the same results. Therefore, the antibiotic 
therapy was changed to vancomycin (1 g/day), and the in-
dwelling double-lumen catheter was removed because of 
suspected catheter-related infection. Follow-up blood cul-
tures were negative, and the patient recovered fully.
1. Identification
Initially, the “diphtheroid-like organisms” were identified 
as C. diphtheriae by an API Coryne strip (bioMerieux, Marcy 
l’Etoile, France). Later, 16S rRNA sequence analysis was per-
formed to confirm the species, as described previously [4]. 
The isolate exhibited 99.1% identity with C. amycolatum 
CIP 103452T (GenBank accession no.: X82057), and VITEK 
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2 Anaerobe and Corynebacterium Identification Card (bio-
Merieux) analysis confirmed the presence of C. amycolatum 
with a probability of 99.0%.
2. Susceptibility testing
To study the multidrug resistance phenotype of C. amy-
colatum, we measured the minimum inhibitory concentra-
tions (MICs) of penicillin, ampicillin, imipenem, ciproflox-
acin, gentamicin, and vancomycin for this isolate by using 
Etest (AB bioMerieux, Solna, Sweden). The MIC values are 
shown in Table 1; ciprofloxacin had the highest MIC value 
of >32 µg/mL. To elucidate the mechanism underlying the 
high-level ciprofloxacin resistance, we analyzed the sequence 
of the quinolone resistance-determining region of the gyrA 
gene, as described by Sierra et al. [5]. This isolate showed 
novel mutations in the gyrA gene, wherein the codon for 
Ser-87 mutated to form an Ile codon and the codon for Asp-
91 mutated to a Gly codon (GenBank accession no.:EU835887, 
Table 2).
DISCUSSION
Although its pathogenic role was apparent only in few 
cases, C. amycolatum, like Corynebacterium striatum, can 
cause endocarditis, bacteremia, and catheter exit-site infec-
tion. In cases wherein clinically significant infection by any 
of the coryneform bacteria is suspected, species identifica-
tion and antibiotic susceptibility determination are impor-
tant to decide and administer the optimal antibiotic and 
treatment regimens. However, possibilities like misidentifi-
cation of species or non-availability of adequate data for us-
ing automated kits with identification cards should be con-
sidered. Genotypic assays such as 16s rRNA sequencing 
may be required to confirm the identity of species. In this 
present case, the clinical isolate showed a high level of resis-
tance to ciprofloxacin (MIC value of >32 µg/mL), probably 
due to the novel mutation in the gyrA gene, wherein the co-
don for Ser-87 mutated to form an Ile codon and the codon 
for Asp-91 mutated to a Gly codon [6]. Therefore, in cases 
of suspected Corynebacterium spp. infection, the physician 
and the microbiologists in laboratories should confirm the 
antibiotic susceptibility patterns of the clinical isolates to 
help decide the optimal antibiotic and treatment regimens.
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Table 2. Mutations observed in the quinolone resistance-determining re-
gions of the gyrA gene of Corynebacterium amycolatum isolates and their 
ciprofloxacin MIC values
Isolates
Amino acid sequence of gyrA* Ciprofloxacin
MIC (µg/mL)87 88 89 90 91
C. amycolatum (#1008)† Ser Ala Ile Tyr Asp 0.064
C. amycolatum (#1049)† Arg Ala Ile Tyr Asp >32
C. amycolatum (#1009)† Arg Pro Ile Tyr Asp >32
C. amycolatum (#1011)† Arg Ala Val Tyr Asp >32
Isolate (EU835887) Ile Ala Ile Tyr Gly >32
*The amino acid position number was obtained from the amino acid sequence of the 
gyrA gene of Corynebacterium glutamicum; †Data reproduced from Sierra et al. [2].
Abbreviations: MIC, minimum inhibitory concentration; Ser, serine; Ala, alanine; Ile, 
isoleucine; Tyr, tyrosine; Asp, aspartate; Arg, arginine; Pro, proline; Val, valine; Gly, 
glycine
Table 1. MIC values for Corynebacterium amycolatum 
Antibiotics MIC* (µg/mL)
MIC† (µg/mL)
range MIC50 MIC90
Penicillin 0.19 ≤0.12–>4 1 >4
Ampicillin   0.125 ≤0.25–>8 4 >8
Imipenem   0.032 ≤0.25–0.5 ≤0.25 ≤0.25
Ciprofloxacin >32 ≤0.25–>4 >4 >8
Gentamicin 8 ≤1–>8 4 >4
Vancomycin   0.032 ≤0.5–2 ≤0.5 8
*in this case; †MIC values were determined in 60 strains of C. amycolatum by using the 
method described by Gómez-Garcés et al. [6].
Abbreviation: MIC, minimum inhibitory concentration
